Bone Abstracts

Contents

• Invited Speaker Abstracts
• • (1)
  • • Highlights in basic bone research

      ba0007is1
    • Highlights in clinical bone research

      ba0007is2
    • Biomechanics of fetal movements

      ba0007is3
    • Mechanical loading and bone development - insights from epidemiological studies

      ba0007is4
    • Spine development

      ba0007is5
    • Nutritional rickets - a socioeconomic problem

      ba0007is6
    • Effect of vitamin D on body composition

      ba0007is7
    • Vitamin D in pregnancy and offspring immunology

      ba0007is8
    • Osteoclast disorders

      ba0007is9
    • Endoplasmic reticulum stress in osteoblasts

      ba0007is10
    • Clock genes and bone and mineral regulation

      ba0007is11
    • Orthopaedic management of osteogenesis imperfecta in the bisphosphonate era

      ba0007is12
    • Craniosynostoses in rare skeletal disorders

      ba0007is13
    • Orthopedic needs in X-linked hypophosphatemic rickets

      ba0007is14
    • Diagnosis of bone dysplasia

      ba0007is15
    • Current care and new therapeutic approaches to achondroplasia

      ba0007is16
    • TGF-beta inhibition in osteogenesis imperfecta

      ba0007is17
    • Anti-resorptive therapy for the treatment of pediatric bone disorders: where do we go from here?

      ba0007is18
• Oral Communications
• • (1)
  • • Association between age at puberty and bone accrual up to 25 years-old

      ba0007oc1
    • Adolescent pregnancy and bone density in premenopausal women

      ba0007oc2
    • Osteocyte lacunae characteristics in healthy children

      ba0007oc3
    • Early life vitamin D depletion and mechanical loading determine methylation changes in the RXRA, Runx2 and osterix promoters in mice

      ba0007oc4
    • Low birthweight is associated with poorer limb muscle mass and grip strength in middle age: findings from the UK Biobank Imaging Enhancement

      ba0007oc5
    • Anthropometric characteristics of pediatric patients with hypophosphatasia: data from the Global Hypophosphatasia Patient Registry

      ba0007oc6
    • Comparison of zoledronate and pamidronate in children with skeletal disorders: Short term safety experience from a single institution

      ba0007oc7
    • Bisphosphonate improves hip range of motion and pain but not femoral head sphericity: A multicentre, randomized clinical trial of children with Perthes disease

      ba0007oc8
    • Efficacy and safety of intravenous zoledronic acid for the treatment of pediatric glucocorticoid-induced osteoporosis: An international, randomized placebo-controlled trial

      ba0007oc9
    • Next-generation antibody-guided enzyme replacement therapy for lysosomal storage diseases

      ba0007oc10
    • Targeting adeno-associated viral vectors to fractures and the skeleton

      ba0007oc11
    • Combination treatment of a novel activin receptor IIB ligand trap and zoledronate improves muscle and bone proprieties in a mouse model of osteogenesis imperfecta

      ba0007oc12
    • Analysis of osteogenesis imperfecta in pathology and the effects of 4-phenylbutyric acid using patient-derived fibroblasts and induced pluripotent stem cells

      ba0007oc13
    • Burosumab resulted in greater improvement in clinical outcomes than continuation with conventional therapy in younger (1-4 years-old) and older (5-12 years-old) children with X-linked hypophosphatemia

      ba0007oc14
    • Sustained efficacy and safety of burosumab, a fully human anti-FGF23 monoclonal antibody, in children and early adolescents with X-linked hypophosphatemia

      ba0007oc15
    • A natural history study of generalized arterial calcification of infancy (GACI) and autosomal recessive hypophosphatemic rickets (ARHR2) due to ENPP1 or ABCC6 deficiency: interim analysis

      ba0007oc16
    • Growth curves for children with X-linked hypophosphatemia

      ba0007oc17
    • Developing a human-mouse hybrid model of osteogenesis imperfecta for investigating new therapies for children

      ba0007oc18
    • Altered 3 hydroxylation complex in bone homeostasis

      ba0007oc19
    • Identifying the role of NBAS in bone fragility using zebrafish and exploring therapeutic targets to reverse NBAS activity

      ba0007oc20
    • New mouse model with IFITM5 S42L for atypical type VI osteogenesis imperfecta

      ba0007oc21
    • Bone tissue phenotyping reveals increased matrix mineralization, elevated osteocyte lacunar density and altered vascularity in a new OI mouse model carrying a leucine substitution for the BRIL p.Serine42 residue

      ba0007oc22
    • Effects of the FGF2 aptamer on growth plate cartilage development of achondroplasia patient-specific iPS cells in a xenograft model

      ba0007oc23
    • TA-46, a recombinant soluble FGFR3 receptor for the treatment of achondroplasia, is safe and well-tolerated in healthy volunteers

      ba0007oc24
    • TransCon CNP: Potential for a once weekly novel therapy in children with achondroplasia

      ba0007oc25
    • [18F] NaF PET/CT the first tool to diagnose chronic activity in FOP at all ages?

      ba0007oc26
    • Palovarotene inhibits the development of new heterotopic ossification in fibrodysplasia ossificans progressiva (FOP)

      ba0007oc27
• Poster Presentations
• • (1)
  • • Abstract unavailable

      ba0007p1
    • Treatment of partial growth arrest using cylindrical costal osteochondral graft

      ba0007p2
    • Abstract unavailable

      ba0007p3
    • Applicability of the Tanner-Whitehouse 3 method to United Kingdom children born in the 21st century

      ba0007p4
    • Response of bone to mechanical stimulation in the offspring of MAVIDOS study mothers in a single centre; the effect of antenatal vitamin D supplementation

      ba0007p5
    • Pseudohypoparathyroidism type Ib initially masquerading as epileptic seizures due to Fahr's disease

      ba0007p6
    • Bone morphology patterns in children with osteogenesis imperfecta

      ba0007p7
    • Polyhydramnios: sole risk factor for non-traumatic fractures in two infants

      ba0007p8
    • Do lifestyle factors play a role on bone health in boys diagnosed with Autism Spectrum Disorder? Preliminary data from the Promoting bone and gut health in our children (PROUD) study

      ba0007p9
    • Radiographic evidence of zoledronic acid given during pregnancy - a case report

      ba0007p10
    • Reference values of cortical thickness, bone width, and Bone Health Index in metacarpals of children from age 0 y, as determined with an extension of the fully automated BoneXpert bone age method

      ba0007p11
    • Abstract unavailable

      ba0007p12
    • Clinical implications of modeling the maturational spurt

      ba0007p13
    • Bone health in children with congenital heart disease

      ba0007p14
    • TA-46 prevents premature synchondrosis and restores foramen magnum size in a mouse model of achondroplasia

      ba0007p15
    • Higher neonatal bone mineral content and lower IL-6 levels in offspring of overweight/obese women following antenatal exercise: The IMPROVE randomized controlled trial (RCT)

      ba0007p16
    • Sex and maturation effects on trabecular and cortical microarchitecture in children and young adults

      ba0007p17
    • Bone mass and fracture prevalence in childhood brain cancer survivors (CBCS) 2 or 5 years after off therapy

      ba0007p18
    • Progresive-deforming form of osteogenesis imperfecta in neonates - own experience

      ba0007p19
    • Abstract unavailable

      ba0007p20
    • Efficacy and safety of intravenous infusion of ibandronic acid in children with osteogenesis imperfecta

      ba0007p21
    • Tibia microarchitecture in children with recent fractures

      ba0007p22
    • What happens to the skeleton at the time of diagnosis of paediatric cancer?

      ba0007p23
    • The role of the RACK1-c-Src axis in regulation of osteoclast function

      ba0007p24
    • Short term mechanical stimulation using whole body vibration identifies differences in bone response between prepubertal boys with and without prior fracture

      ba0007p25
    • Parathyroid hormone is higher in infants with fracture as opposed to without fracture undergoing skeletal survey for suspected non-accidental injury, and is inversely associated with mean corpuscular haemoglobin content

      ba0007p26
    • Response to mechanical stimulation of bone in children with osteogenesis imperfecta and the effect of bisphosphonate therapy

      ba0007p27
    • Duchenne muscular dystrophy: preliminary results of the Risbo-DMD study

      ba0007p28
    • Rib cage anomalies in a cohort of osteogenesis imperfecta patients

      ba0007p29
    • Bone mass, sclerostin and body composition in women with anorexia nervosa: a 3-year follow-up after weight gain therapy

      ba0007p30
    • Determinants of survival in osteogenesis imperfecta (OI) Type II

      ba0007p31
    • Successful use of oral acetazolamide in symptomatic subcutaneous calcifications in hyperphosphatemic tumoral calcinosis

      ba0007p32
    • Unusual case of severe hypophosphataemic rickets and renal stones associated with valproate use

      ba0007p33
    • Bone metabolism and bone mineral density in Duchenne muscular dystrophy

      ba0007p34
    • Atypical fractures in pediatric patients with osteogenesis imperfect treated with zoledronic acid

      ba0007p35
    • ALPL gene mutation in a family

      ba0007p36
    • Generation of osteogenesis imperfecta type XIV zebrafish models

      ba0007p37
    • Clinical features and approach to treatment in pediatric patients with McCune-Albright syndrome: monocentric experience

      ba0007p38
    • Bone health outcomes in children with Duchenne Muscular Dystrophy

      ba0007p39
    • Stature and body weight more than age explain functionality level in children with Osteogenesis Imperfecta

      ba0007p40
    • Increased prevalence of fractures in poorly chelated children with beta thalassemia

      ba0007p41
    • FGF 23 measurements in children with fibrous dysplasia: useful or not?

      ba0007p42
    • Bone health is compromised in adult patients with childhood-onset autoimmune-polyendocrinopathy-candiadis-ectodermal dystrophy (APECED)

      ba0007p43
    • Bone mass and vertebral fractures in South African (SA) children on prolonged oral glucocorticoids (GCs) for chronic non-malignant illnesses

      ba0007p44
    • Osteogenesis imperfecta type 15 with neurological phenotype associated with homozygous WNT1 mutation and uniparental isodisomy for chromosome 12

      ba0007p45
    • Vertebral fractures are more prevalent than long bone fractures in boys with glucocorticoid-treated Duchenne Muscular Dystrophy: Results of a prospective observational study

      ba0007p46
    • Anorexia nervosa: weighing in on bone health surveillance: When should it be performed?

      ba0007p47
    • Does improved genetic screening make it more difficult to diagnose Osteogenesis Imperfecta?

      ba0007p48
    • Bone mineral density and vitamin D status in children with chronic neurological syndromes - clinical observations

      ba0007p49
    • Treatment with asfotase alfa for patients with infantile hypophosphatasia and screening plan of hypophosphatasia by low ALP level and dental findings in Korea

      ba0007p50
    • Higher dose of burosumab is needed for treatment of children with severe forms of X-linked hypophosphatemia

      ba0007p51
    • Variable familial expression of spondylometaphyseal dysplasia with coxa vara and a novel FN1 mutation

      ba0007p52
    • Successful treatment with enzyme replacement therapy in a girl with severe infantile Hypophosphatasia

      ba0007p53
    • Is oral health correlated with skeletal phenotype in primary metabolic bone diseases? A preliminary report of the Greek experience

      ba0007p54
    • Abstract unavailable

      ba0007p55
    • Unusual cause of abdominal pain in adolescent girl

      ba0007p56
    • Effective therapy with growth hormone of an adolescent patient with growth hormone deficiency and osteopetrosis: A case report

      ba0007p57
    • The validity of serum alkaline phosphatase to identify nutritional rickets in Nigerian children on a calcium-deprived diet

      ba0007p58
    • Effective treatment of a patient with Hypophosphatemic Rickets leading to normal adult height

      ba0007p59
    • FGF23-expressing osteocytes are confined to bone packets that completed primary mineralization in patients with chronic kidney disease on dialysis (CKD5D)

      ba0007p60
    • Biochemical and genetic analysis in patients with odontohypophosphatasia in Japan

      ba0007p61
    • Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in-vitro mutagenesis model

      ba0007p62
    • Bone geometry and microarchitecture deficits in children with Alagille syndrome

      ba0007p63
    • Missense mutations in ENPP1 result in osteoporosis in patients and is recapitulated in the ENPP1 loss of function murine model

      ba0007p64
    • Tumor induced osteomalacia in a 12-year-old girl: Case report

      ba0007p65
    • Bone densitometry and body composition in children with hypophosphatasia

      ba0007p66
    • Bone health outcomes in children and adolescents with neuromuscular disease

      ba0007p67
    • Clinical case of a child with a hereditary vitamin D dependent rickets type 1a, complicated by rachitic lung and oxygen dependence

      ba0007p68
    • Experience of implementation and monitoring of burosumab treatment in a multi-disciplinary setting

      ba0007p69
    • Metabolic bone disease of prematurity - comparing neonatal and endocrine approaches using a nationwide survey

      ba0007p70
    • Necessity of high dose and prolonged duration denosumab post stem cell transplant for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis

      ba0007p71
    • Burosumab experience in UK X-linked hypophosphataemia children under five years old

      ba0007p72
    • Burosumab initiation in a UK X-linked hypophosphataemia cohort: real-world use resonates with research evidence

      ba0007p73
    • Burosumab can improve pain and quality of life for children with X-linked hypophosphataemia and their families: a London centre's experience

      ba0007p74
    • Active vitamin D analogues and oral phosphate for the treatment of X-linked hypophosphataemia in paediatric patients: A systematic literature review and survey of expert opinion on current needs

      ba0007p75
    • Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis

      ba0007p76
    • Long-term efficacy profile of asfotase alfa in the treatment of patients with hypophosphatasia: a pooled analysis

      ba0007p77
    • Abstract unavailable

      ba0007p78
    • Novel imaging approaches to the quantification of musculoskeletal alterations in X-linked hypophosphatemic rickets (XLH)

      ba0007p79
    • Characterization of pain in patients with fibrous dysplasia

      ba0007p80
    • Bone health in adolescent females with anorexia nervosa may be preserved by high lean mass

      ba0007p81
    • Tertiary hyperparathyroidism and post-operative hungry bone syndrome in a patient with X-linked hypophosphatemic rickets

      ba0007p82
    • Could digital X-ray radiogrammetry be an alternative for dual energy X-ray absorptiometry

      ba0007p83
    • Abstract unavailable

      ba0007p84
    • Neonatal calcinosis cutis due to a mutation in the GNAS gene

      ba0007p85
    • Disease-specific pathological traits of youth at risk of secondary osteoporosis as determined through peripheral Quantitative Computed Tomography

      ba0007p86
    • Assessment of bone density by DXA in poorly controlled children with β-Thalassemia: Correction for hepatic iron - overloadby manual analysis

      ba0007p87
    • Diagnostic performance of morphometric vertebral fracture analysis (MXA) in children using a 33-point software programme

      ba0007p88
    • Use of DXA and pQCT measurements to screen for fracture risk in 3 to 18 year old poorly chelated thalassaemic children

      ba0007p89
    • Osteogenesis imperfecta due to FKBP10 mutation- shift from high to low bone turnover

      ba0007p90
    • Bone health index by hand X-ray compared with bone mineral density by dual-energy X-ray absorptiometry in children with Duchenne muscular dystrophy

      ba0007p91
    • A little girl with bowing of legs, a short mother and a waddling sister: Metaphyseal Chondrodysplasia, Schmid type

      ba0007p92
    • Assessing the ability of vibration analysis to differentiate wrist and ankle fractures from sprains in children

      ba0007p93
    • Characteristics of ultradistal radius bone density during childhood: results from the Bone Mineral Density in Childhood Study

      ba0007p94
    • Detection of intact FGF23 using a novel well-characterized ELISA

      ba0007p95
    • Radiofrequency echographic multispectrometry (REMS): a new approach for osteoporosis diagnosis in adolescents

      ba0007p96
    • Association of serum alkaline phosphatase with radiological rickets severity in children with X-linked hypophosphataemia on conventional therapy

      ba0007p97
    • The effect of vitamin D on bone health assessed by radiogrammetry: a double-blind placebo-controlled vitamin D supplementation trial in infants

      ba0007p98
    • Pre and post-natal achondroplasia, retrospective series of 64 consecutives cases with analyze of the diagnostic methods and timing issues

      ba0007p99
    • High-resolution MRI assessment of the muscle-fat-bone unit in young adults with childhood onset Crohn's disease

      ba0007p100
    • Vitamin D levels among Lebnaese children: Do we need to alter normal level?

      ba0007p101
    • Vitamin D deficiency in children in Israel: A cross-sectional study and possible associated factors

      ba0007p102
    • Abstract unavailable

      ba0007p103
    • Vitamin D deficiency nutritional rickets presenting to secondary care in children (<16 Years) - A United Kingdom surveillance study

      ba0007p104
    • Respiratory health impacts quality of life for adults with OI

      ba0007p105
    • Scoliosis and cardiopulmonary outcomes in adults with osteogenesis imperfecta: a pilot study

      ba0007p106
    • Sex differences in the longitudinal associations between body composition and bone stiffness index in European children and adolescents

      ba0007p107
    • Abstract unavailable

      ba0007p108
    • Fracture prevalence in children 0-19 years-old in Mexico: A 10-year cross-sectional analysis

      ba0007p109
    • Cost-effectiveness of a Vitamin D supplementation programme in pregnant women and children to prevent rickets in the UK

      ba0007p110
    • Vitamin D dependent rickets type 1 caused by CYP27B1 mutation

      ba0007p111
    • Case report: investigation of an osteolytic lesion leading to the diagnosis of congenital generalized lipodystrophy due to a novel AGPAT2 mutation

      ba0007p112
    • Next-generation sequence and biomarker levels in the patients with early-onset chronic non-bacterial osteomyelitis from North Caucasian region of Russia

      ba0007p113
    • Hypophosphatasia in Japan: ALPL mutation analysis in 98 patients

      ba0007p114
    • Mabry Syndrome is a cause of hyperphosphatasia and mental retardation

      ba0007p115
    • Molecular genetic diagnosis and genotype-phenotype correlations in children and adolescents with recurrent fractures

      ba0007p116
    • Use of Lego® to explain genetic variations in type 1 collagen - a pilot study

      ba0007p117
    • Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome

      ba0007p118
    • A novel mutation in FAM111A gene in child with Kenny-Caffey syndrome type 2 presenting with short statue, medullary stenosis and hypoparathyroidism

      ba0007p119
    • Mutational and phenotypic spectra in 137 Russian patients with inherited forms of rickets

      ba0007p120
    • An Acvr1[R258G] ‘conditional on' mouse model of atypical fibrodysplasia ossificans progressiva (FOP) is Activin A dependent

      ba0007p121
    • Congenital hyperinsulinism of infancy in a child with autosomal dominant hypocalcaemia type 1 due to an activating calcium sensing receptor mutation

      ba0007p122
    • Odontochondrodysplasia in association with a TRIP11 mutation

      ba0007p123
    • Heterozygous CDC73 mutation causing parathyroid adenoma in an adolescent girl presenting with mental health issues

      ba0007p124
    • SCN8a mutations and osteoporosis. Is osteocyte dysfunction the cause or the consequence?

      ba0007p125
    • Anemia - novel clinically significant finding during intravenous pamidronate therapy of children diagnosed with osteogenesis imperfecta

      ba0007p126
    • Burosumab therapy in pediatric patients with X-linked hypophosphatemia improves body composition

      ba0007p127
    • Growth hormone effect on bone mineral density in a girl with osteogenesis imperfecta - a case presentation

      ba0007p128
    • A smartphone-based survey of frequency and severity of adverse effects following bisphosphonate therapy in a Tertiary Paediatric Centre

      ba0007p129
    • Off label uses of pamidronate in rare pediatric bone diseases (Jansen's Metaphyseal Chondrodysplasia and Generalized Arterial Calcification of Infancy): A four year perspective

      ba0007p130
    • Use of intravenous pamidronate in pediatric acute lymphoblastic leukemia patients with osteonecrosis (ON) results in reduced pain and improved radiologic outcome of ON lesions: Long- term follow-up over 15-years

      ba0007p131
    • A prospective study of 17 consecutive pediatric patients with chronic non-bacterial osteomyelitis treated with intravenous pamidronate over a 15 year period at a single center reveals excellent clinical and radiologic outcome initially and after flare

      ba0007p132
    • Losartan reduces circulating TGFb and CTX and increases vertebral bone mass in the OIM mouse

      ba0007p133
    • First report of skin reaction with Zoledronic Acid

      ba0007p134
    • Oral ibandronate therapy in patients with osteogenesis imperfecta

      ba0007p135
    • Intravenous bisphosphonate treatment in severe infantile hypercalcemia associated with Williams Syndrome

      ba0007p136
    • Reversion to pamidronate after switch to zoledronic acid in children with bone disease

      ba0007p137
    • How early is early enough - Bisphosphonate treatment in Osteogenesis imperfecta

      ba0007p138
    • Growth hormone therapy in a child with severe short stature due to Miller-McKusick-Malvaux (3M) syndrome-2

      ba0007p139
    • Safety and effectiveness of stoss therapy in children

      ba0007p140
    • Hypercalcaemia and osteonecrosis of the jaw in association with denosumab use in the paediatric population

      ba0007p141
    • Protocol: a randomized trial of zoledronate in children with cerebral palsy

      ba0007p142
    • Intermittent bi-daily sub-cutaneous teriparatide infusion in children with hypoparathyroidism: a single-centre experience

      ba0007p143
    • A multi-criteria decision analysis of the value of burosumab for the treatment of paediatric patients with X-linked hypophosphatemia in Portugal

      ba0007p144
    • Nine-month follow-up data on biochemical, clinical, radiological and functional parameters in a clinical cohort of children at Evelina London Children's Hospital with X-linked hypophosphataemia treated with Burosumab

      ba0007p145
    • Does prior bisphosphonate therapy in children and adolescents with cerebral palsy alter surgical outcomes?

      ba0007p146
    • Changes in DXA Z-scores during bisphosphonate (BP) therapy in patients with osteogenesis imperfecta (OI) at a tertiary care hospital in South Africa

      ba0007p147
    • Management of foramen magnum stenosis in patients with achondroplasia: relative merit of clinical and radiological indications for foramen magnum decompression

      ba0007p148
    • Bone mineral changes in 43 children with osteogenesis imperfecta treated by pamidronate

      ba0007p149
    • Osteogenesis imperfecta: skeletal outcomes after bisphosphonates discontinuation at final height

      ba0007p150
    • The safety and efficacy of denosumab versus zoledronic acid in the treatment of pediatric osteoporosis: a randomized controlled pilot trial

      ba0007p151
    • An evaluation of the rebound phenomenon during denosumab therapy in children with low turnover osteoporosis

      ba0007p152
    • Long-term growth hormone treatment alters glucose metabolism in achondroplasia

      ba0007p153
    • Self-reported sedentary time is negatively associated with microarchitecture of the tibia

      ba0007p154
    • Gender specific paediatric reference data for muscle function parameters assessed using jumping mechanography

      ba0007p155
    • Patients with nephropatic cystinosis display lower cortical thickness and grip strength

      ba0007p156
    • Gonadotrophin releasing hormone analogues utilised in late and post-pubertal adolescents causes a reduction in bone density in transgender teenagers attending a national gender dysphoria clinic

      ba0007p157
    • Association of grip strength and body composition in Indian boys and girls

      ba0007p158
    • Determinants of muscle function in 6 to 11 year old rural Indian children

      ba0007p159
    • Assessment of muscle mass and function in Indian children with type 1 diabetes

      ba0007p160
    • Endocrinological complications in Czech paediatric patients with Duchenne muscular dystrophy

      ba0007p161
    • Bone monitoring and morbidity in adults with duchenne muscular dystrophy: Challenges in implementation of standards of care

      ba0007p162
    • Prenatal oligohydramnios is associated with hip shape in adolescent males

      ba0007p163
    • Musculoskeletal deficits persist up to two years despite anti-TNF-alpha antibody therapy in children with Crohn's disease: Results of a prospective, observational inception cohort study

      ba0007p164
    • Fibroblast growth factor-21 (FGF-21) - marker of mineral bone disorder

      ba0007p165
    • The ketogenic diet and bone density: a retrospective longitudinal cohort study

      ba0007p166
    • Children's multivitamins do not contain sufficient vitamin D

      ba0007p167
    • Abstract unavailable

      ba0007p168
    • Rescue diet restores bone matrix mineralization in mice with a non-functioning vitamin D receptor

      ba0007p169
    • Serum 25-hydroxyvitamin D requirements to prevent rickets in Nigerian children on a calcium-deprived diet

      ba0007p170
    • Seasonal variations in vitamin D status in children with haematological malignancies in Sweden

      ba0007p171
    • Cow's milk allergic infants on amino acid-based medical nutrition formula maintain adequate serum concentrations of phosphorus, calcium and magnesium despite the use of acid-suppressive medication

      ba0007p172
    • Motor and nutritional aspects of individuals with osteogenesis imperfecta assisted in Brazilian midwest region

      ba0007p173
    • Supplementation of children with type 1 diabetes with milk or pharmacological calcium for improving bone health - a randomized controlled trial

      ba0007p174
    • Dietary behaviours and compromised nutritional intakes in children with Osteogenesis Imperfecta

      ba0007p175
    • Prevalence of vitamin D deficiency in newly diagnosed children with cancer

      ba0007p176
    • Feasibility of a 13-week targeted exercise intervention on tibial bone mineral density in adolescents with Developmental Coordination Disorder

      ba0007p177
    • The role of hydrotherapy in the management of children with severe Osteogenesis Imperfecta

      ba0007p178
    • Clinical and radiological characteristics of children's forearm deformations with hereditary multiple exostosis (Clinical observation)

      ba0007p179
    • A retrospective review of modern spine surgery in the skeletal dysplasia population

      ba0007p180
    • Walking quality of children with healed Perthes disease

      ba0007p181
    • Handgrip strength as functionality and independence indicative in Osteogenesis Imperfecta

      ba0007p182
    • Functional outcomes of an adult with Osteogenesis Imperfecta after rehabilitation post-bilateral Girdlestone procedure: a case report

      ba0007p183
    • Material based on bioactive glass to replace bone defects in children after removal of tumors

      ba0007p184
    • High impact exercise to improve musculoskeletal outcomes in Crohn's disease: a feasibility questionnaire

      ba0007p185
    • Severe osteoporosis with life threatening vertebral fractures in a 15-years-old boy with juvenile idiopathic arthritis: a successful spinal cord decompression and posterior spinal fusion Th2-Th12

      ba0007p186
    • Increased prevalence of overweight and obesity and its clinical predictors in children affected by X-linked hypophosphatemia

      ba0007p187
    • Impact of type 1 diabetes mellitus on skeletal integrity and strength in adolescents aged 12 to 16 years; as assessed by High Resolution peripheral Quantitative Computed Tomography (HRpQCT)

      ba0007p188
    • Cleidocranial dysplasia: a patient with severe dental phenotype

      ba0007p189
    • Cone-shaped epiphyses involving the knees: report of a case and differential diagnosis

      ba0007p190
    • Supporting the emotional well-being of children living with osteogenesis imperfecta; an upstream health promotion initiative

      ba0007p191
    • Developing a high chair to meet the needs of infants with Achondroplasia; a collaboration between Evelina London Children's Hospital and Brunel University

      ba0007p192
    • Double trouble: A case of trisomy 21 and achondroplasia

      ba0007p193
    • Skeletal dysplasia in Saul Wilson syndrome

      ba0007p194
    • Growth velocity measured by biomarker, COLX, in Achondroplasia

      ba0007p195
    • Sleep related problems in children with osteogenesis imperfecta

      ba0007p196
    • A playful type of intervention for infants with osteogenesis imperfecta

      ba0007p197
    • The multidisciplinary team (MDT) approach: What does it look like and why does it matter? An illustration of a true MDT approach to provide holistic care for a child with severe and complex osteogenesis imperfecta

      ba0007p198
    • Diversity of outcomes in randomised trials of interventions for children with osteogenesis imperfecta

      ba0007p199
    • Whole body vibration training for children and adolescents with congenital myopathy

      ba0007p200
    • Juvenile dermatomyositis (JDM) and hypoparathyroidism (HP) in an adolescent girl

      ba0007p201
    • Vibration therapy improves mobility and has no detrimental impact on bone health in adolescents with mild cerebral palsy independent of daily protocol duration (9 minutes/day vs. 15 minutes/day)

      ba0007p202
    • Side-alternating vibration training improves mobility and has no detrimental impact on bone health in young children with mild-moderate cerebral palsy

      ba0007p203
    • A qualitative analysis of the burden-of-illness associated with X-linked hypophosphataemia (XLH) in children and adolescents

      ba0007p204
    • Bone mineral density in surgical hemivertebrae treatment in a prematurely born child − a case study

      ba0007p205
    • Robot-assisted exercises in children with cerebral palsy - a case study

      ba0007p206
    • Group exercises aimed at poor body posture correction assisted by humanoid robot - A case study

      ba0007p207
    • Motor developmental outcomes in 2 babies with very severe osteogenesis imperfecta (type II)

      ba0007p208
    • Persistently low trabecular bone mineral density and normal bone strength at the radius over 3 years after simultaneous pancreas kidney transplantation

      ba0007p209
    • Premature physeal closure following 13 -cis - retinoic acid administration in neuroblastoma

      ba0007p210
    • Value of osteogenesis imperfecta clinical nurse specialists to families and consultants across five UK centres

      ba0007p211
    • Genetic loss of heparanase does not inhibit osteochondromas in Ext1 and Ext2 double heterozygous hereditary multiple osteochondroma mouse model

      ba0007p212
    • Evaluating a therapy-led school and nursery outreach service for children with Osteogenesis Imperfecta

      ba0007p213
    • Assessment of multidisciplinary care of children with osteogenesis imperfecta at The Royal Manchester Children's Hospital

      ba0007p214
    • Evaluating the natural history of subcutaneous fat necrosis

      ba0007p215
    • Dual diagnosis of autism and osteogenesis imperfecta: Case examples to illustrate the implications of dual diagnosis for enhanced outcomes for child and family

      ba0007p216
    • Abstract unavailable

      ba0007p217
    • Hypercalcemia and parathyroid hormone-related peptide expression in a 3 months old boy with Colon Hemangioendothelioma

      ba0007p218
    • Comparison of cell separation methods, using relative expression of specific growth plate zone markers in a pig model

      ba0007p219
    • New perspectives in diagnosis and management of optic neuropathy in fibrous dysplasia: utility of optical coherence tomography and computed tomography measurements

      ba0007p220
    • Speech and hearing impairment and respiratory complications in a large cohort of patients with Achondroplasia

      ba0007p221
    • Long-term clinical outcome in chronic recurrent multifocal osteomyelitis (CRMO): the Leiden cohort

      ba0007p222
    • A preliminary data of a prospective study on Iranian patients with osteogenesis imperfecta

      ba0007p223
    • A teenager with recurrent fractures and multiple bone lesions: a diagnostic challenge

      ba0007p224
    • A short girl with severe scoliosis and osteoporosis

      ba0007p225
    • The experience of canakinumab in 2 patients with primary tumor (tumoral) calcinosis

      ba0007p226
• Late Breaking Abstracts
• • (1)
  • • Genetic inactivation of osteocalcin in Col1a1Jrt/+ mice, a model of dominant osteogenesis imperfecta, restores glucose metabolism to wild-type levels

      ba0007lb1
    • Lumbar spine quantitative computed tomography (QCT) is a better predictor of vertebral fracture in boys with Duchenne muscular dystrophy (DMD) than either DXA or peripheral QCT

      ba0007lb2
    • CD64: An adjunct to Kocher's criteria to differentiate septic arthritis and transient synovitis in children

      ba0007lb3
    • Impact of pubertal suppression on body composition and bone density in adolescents with gender dysphoria

      ba0007lb4
    • Chronic recurrent multifocal osteomyelitis in children with hypophosphatasia explained by anti-inflammatory nucleotidase activity of tissue nonspecific alkaline phosphatase in mesenchymal and hematopoietic cells

      ba0007lb5
    • Abstract unavailable

      ba0007lb6
    • Validation study of automated bone age assessment in 1285 children and adolescents aged 5 to 16 years

      ba0007lb7
    • Abstract unavailable

      ba0007lb8
    • Monitoring skull base abnormalities in children with osteogenesis imperfecta

      ba0007lb9
    • Foramen magnum stenosis (FMS): neuroradiological aspects before and after cervical decompression in paediatric patients with achondroplasia (ACH)

      ba0007lb10